These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21262635)

  • 1. Cattle Health Certification Standards and BVDV control.
    Brigstocke T
    Vet Rec; 2010 Nov; 167(21):834-5. PubMed ID: 21262635
    [No Abstract]   [Full Text] [Related]  

  • 2. The control of bovine viral diarrhoea virus in Europe: today and in the future.
    Lindberg A; Brownlie J; Gunn GJ; Houe H; Moennig V; Saatkamp HW; Sandvik T; Valle PS
    Rev Sci Tech; 2006 Dec; 25(3):961-79. PubMed ID: 17361763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BVD-approach: the helm is the other way].
    Verberne LR
    Tijdschr Diergeneeskd; 2004 Feb; 129(3):95-6. PubMed ID: 14976676
    [No Abstract]   [Full Text] [Related]  

  • 4. Continued BVDV education needed.
    Bezek D
    J Am Vet Med Assoc; 1997 Jan; 210(2):167. PubMed ID: 9018340
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
    Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of two-step vaccination in the control of bovine viral diarrhoea (BVD).
    Moennig V; Eicken K; Flebbe U; Frey HR; Grummer B; Haas L; Greiser-Wilke I; Liess B
    Prev Vet Med; 2005 Nov; 72(1-2):109-14; discussion 215-9. PubMed ID: 16169620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BVDV: 40 years of effort and the disease still has a firm hold.
    O'Rourke K
    J Am Vet Med Assoc; 2002 Jun; 220(12):1770-3. PubMed ID: 12092944
    [No Abstract]   [Full Text] [Related]  

  • 8. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
    Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
    Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K; Schnackel J; Chase CC
    Vet Ther; 2003; 4(1):24-34. PubMed ID: 12756633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical-virologic course after superinfection of persistently infected cattle with cytopathogenic bovine viral diarrhea virus strains].
    Loehr BI; Frey HR; Moennig V; Greiser-Wilke I
    Dtsch Tierarztl Wochenschr; 1998 May; 105(5):201-4. PubMed ID: 9646556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mental notes in tracking BVDV carriers].
    Laureyns J; Ribbens S; de Kruif A
    Tijdschr Diergeneeskd; 2006 May; 131(9):330-4. PubMed ID: 16711566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
    Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
    Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
    Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
    J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
    Brock KV; McCarty K; Chase CC; Harland R
    Vet Ther; 2006; 7(1):27-34. PubMed ID: 16598681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey on management practices related to the prevention and control of bovine viral diarrhea virus on dairy farms in Indiana, United States.
    Negrón M; Raizman EA; Pogranichniy R; Hilton WM; Lévy M
    Prev Vet Med; 2011 May; 99(2-4):130-5. PubMed ID: 21257213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics in the epidemiology of bovine viral diarrhea virus (BVDV) of relevance to control.
    Lindberg A; Houe H
    Prev Vet Med; 2005 Nov; 72(1-2):55-73; discussion 215-9. PubMed ID: 16214248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
    Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses to non-structural protein 3 (NS3) of bovine viral diarrhoea virus (BVDV) in NS3 DNA vaccinated and naturally infected cattle.
    Young NJ; Thomas CJ; Thompson I; Collins ME; Brownlie J
    Prev Vet Med; 2005 Nov; 72(1-2):115-20; discussion 215-9. PubMed ID: 16169103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosecurity and biocontainment of bovine viral diarrhea virus.
    Smith DR; Grotelueschen DM
    Vet Clin North Am Food Anim Pract; 2004 Mar; 20(1):131-49. PubMed ID: 15062479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.